Triamcinolone controlled-release (EyePoint)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTriamcinolone controlled-release (EyePoint)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPsivida
China Registration ClassN/A

Develop Information

Active CompaniesPsivida
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG